These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Advances in Cutaneous Lupus Erythematosus and Dermatomyositis: A Report from the 4th International Conference on Cutaneous Lupus Erythematosus-An Ongoing Need for International Consensus and Collaborations. Concha JSS; Patsatsi A; Marshak-Rothstein A; Liu ML; Sinha AA; Lee LA; Merola JF; Jabbari A; Gudjonsson JE; Chasset F; Jarrett P; Chong B; Arkin L; Fernandez AP; Caproni M; Greenberg SA; Kim HJ; Pearson DR; Femia A; Vleugels RA; Fiorentino D; Fujimoto M; Wenzel J; Werth VP J Invest Dermatol; 2019 Feb; 139(2):270-276. PubMed ID: 30243657 [No Abstract] [Full Text] [Related]
3. Adverse cutaneous reactions secondary to hydroxychloroquine in patients with dermatomyositis, lupus erythematosus, and lichen planopilaris. Akabane AL; Smith GP J Am Acad Dermatol; 2021 Oct; 85(4):1046-1047. PubMed ID: 33607179 [No Abstract] [Full Text] [Related]
4. Practice and Educational Gaps in Lupus, Dermatomyositis, and Morphea. Fett NM; Fiorentino D; Werth VP Dermatol Clin; 2016 Jul; 34(3):243-50. PubMed ID: 27363879 [TBL] [Abstract][Full Text] [Related]
5. Antimalarial drug toxicities in patients with cutaneous lupus and dermatomyositis: A retrospective cohort study. Mittal L; Zhang L; Feng R; Werth VP J Am Acad Dermatol; 2018 Jan; 78(1):100-106.e1. PubMed ID: 28989103 [TBL] [Abstract][Full Text] [Related]
6. Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous lupus erythematosus. Pelle MT; Callen JP Arch Dermatol; 2002 Sep; 138(9):1231-3; discussion 1233. PubMed ID: 12224986 [TBL] [Abstract][Full Text] [Related]
7. The quinacrine experience in a population of patients with cutaneous lupus erythematosus and dermatomyositis. Mittal L; Werth VP J Am Acad Dermatol; 2017 Aug; 77(2):374-377. PubMed ID: 28711090 [No Abstract] [Full Text] [Related]
9. The involvement of galectin-3 in skin injury in systemic lupus erythematosus patients. Shi Z; Meng Z; Han Y; Cao C; Tan G; Wang L Lupus; 2018 Apr; 27(4):621-627. PubMed ID: 29058991 [TBL] [Abstract][Full Text] [Related]
11. Case of anti-nuclear matrix protein 2 antibody-positive juvenile dermatomyositis preceded by linear cutaneous lupus erythematosus on the face. Miyahara H; Okiyama N; Okune M; Konishi R; Miyamoto M; Hara M; Iwabuchi A; Takada H; Nishino I; Nomura T J Dermatol; 2022 Jan; 49(1):e18-e19. PubMed ID: 34626009 [No Abstract] [Full Text] [Related]